American Medical Association Urges Congress to Avert Devastating Medicare Cuts

Translate to Spanish or other 102 languages!

By introducing a bipartisan agreement today, Congress took a decisive step toward preserving the viability of physician practices and maintaining access to care. Image source:  ama-assn.org
By introducing a bipartisan agreement today, Congress took a decisive step toward preserving the viability of physician practices and maintaining access to care. Image source: ama-assn.org

Mega Doctor News

- Advertisement -

Statement attributable to:
Gerald E. Harmon, M.D.
President, American Medical Association   

“By introducing a bipartisan agreement today, Congress took a decisive step toward preserving the viability of physician practices and maintaining access to care.

“This agreement would postpone substantial reductions in Medicare payment for physician services, providing valuable time for identifying the fundamental system reforms needed to stabilize and support innovation in this critically important program.

- Advertisement -

“We urge the House and Senate to support this bipartisan proposal and join together again in the new year to develop long-term solutions to address the flaws in the Medicare payment system.”

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

How Dogs Benefit Mind and Soul

"Dogs are wonderful greeters. They're waiting for you to come home, and they're always happy to see you. In turn, this increases our feel-good hormones, like dopamine and serotonin,” explained Chivonna Childs, PhD.

Data Reveals US Illicit Fentanyl Use is Double That of Clinical Care

The largest study to date that quantifies and compares medical and illegal use of fentanyl in the United States suggests that illicit use is more than twice as common as medically based use. 

7 Crucial Caregiving Truths Families Often Overlook

If you clicked to read this story, or someone sent it to you, congratulations: You’re a caregiver.

Moderna and Merck Report Positive Phase 3 Results for Personalized Cancer Therapy

Moderna and Merck have reached a major clinical milestone after their investigational individualized cancer therapy, combined with Merck’s Keytruda, produced positive results in a Phase 3 study involving patients with high-risk melanoma.
- Advertisement -